Search for: "WATSON PHARMACEUTICALS "
Results 241 - 260
of 359
Sort by Relevance
|
Sort by Date
23 Nov 2010, 2:19 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
17 Nov 2010, 1:48 am
General Where in the world is pharmaceutical innovation? [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
10 Nov 2010, 1:11 am
Roche (Filewrapper) (Property, intangible) US: Senator Sanders letter to FDA: U.S. needs an ethical pathway for biological products (KEI) (FDA Law Blog) US: Daiichi Sankyo seeks review and correction of patent term adjustment calculation for patent relating to ‘nucleoside and oligonucleotide analogues’ (Patent Docs) US: CAFC in Abraxis v Navinta: remembering Stanford/Roche (IPBiz) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaint against Teva in… [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
19 Oct 2010, 10:42 pm
General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
12 Oct 2010, 8:56 pm
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
23 Sep 2010, 9:20 pm
Before the District Court reached the infringement issue, Solvay, Watson, and... [read post]
23 Sep 2010, 12:39 pm
Karst – On September 22, 2010, Novartis Pharmaceuticals Corporation (“Novartis”) filed a Complaint in the U.S. [read post]
15 Sep 2010, 2:40 am
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP) US: PHOSITA:… [read post]
15 Sep 2010, 2:15 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
23 Aug 2010, 7:15 pm
Magistrate Judge Alan Kay in the District of Columbia to order the Federal Trade Commission to respond to interrogatories about a subpoena it had issued to Paul Bisaro, the CEO of Watson Pharmaceuticals, in a generic-drug investigation. [read post]
17 Aug 2010, 10:51 am
A judge in Washington today ruled the Federal Trade Commission's subpoena seeking the testimony of the chief executive officer of generic drug maker Watson Pharmaceuticals should be enforced. [read post]
10 Aug 2010, 10:50 pm
Austin is filing complaint against three companies, specifically Actavis, Actavis Elizabeth and Watson Pharmaceuticals. [read post]
5 Aug 2010, 2:08 pm
When the Levine, Riegel, and Kent cases were briefed in the United States Supreme Court, we provided our readers with “users’ guides”/”guided tours” that summarized the defense side arguments and pointed out whatever we thought was interesting.Today we’re continuing that tradition with the Bruesewitz (sooner or later we’ll memorize how to spell that) v. [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
27 Jul 2010, 7:18 pm
Magistrate Judge on July 13 ruled that the president and CEO of Watson Pharmaceuticals made a “colorable claim that the FTC may have exceeded its authority by using its investigative power to pressure Watson to enter into a business deal that the FTC considers desirable. [read post]
